Chronic Inflammatory Demyelinating Polyradiculoneuropathy

P. Y.K. Van den Bergh, R. D.M. Hadden, Pierre Bouche, D. R. Cornblath, A. Hahn, I. Illa, C. L. Koski, J. M. Léger, E. Nobile-Orazio, J. Pollard, C. Sommer, P. A. van Doorn, I. N. van Schaik

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationEuropean Handbook of Neurological Management
Subtitle of host publicationSecond Edition
Number of pages9
ISBN (Print)9781405185332
StatePublished - Sep 6 2010


  • Aim to update EFNS/PNS guideline on management of CIDP-based on newly available evidence
  • Chronic inflammatory demyelinating polyradiculoneuropathy
  • Dearth of evidence, concerning general aspects of treatment for symptoms of CIDP-as pain and fatigue
  • Demyelinating polyradiculoneuropathy-and electrodiagnostic criteria
  • Different sets of diagnostic criteria for CIDP-sensitivity and specificity varying
  • Good Practice Points for defining diagnostic criteria for CIDP-initial management
  • Immunosuppressant and immunomodulatory drugs-beneficial in CIDP (Class IV evidence)
  • Intravenous immunoglobulin-showing that IVIg 2.0 g/kg produces significant improvement in disability lasting 2-6 weeks
  • No evidence-based guideline-as none of trials, systematically assessed long-term management
  • Supportive features for diagnosis of CIDP-macrophage-associated demyelination, onion bulb formation, demyelinated and remyelinated nerve fibres

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this